The most widely acknowledged inflammation markers for monitoring chronic and acute disease activity in inflammatory bowel disease (IBD) are C‐reactive protein (CRP), an acute phase protein with a short half-life and total white blood cell count. This evidence concerns the gene CRP and inflammatory bowel disease.